The Medical Technology Directory

 Directory home | Search Directory | How to be listed in the Directory

Zyngenia, Inc.

Founded in 2008, Zyngenia, Inc. is a privately held biotherapeutics company focused on the development of next-generation multi-specific antibody-based therapeutics. The Company uses proprietary patented technology to engineer single molecular entities that may interact with two or more targets.

The multiple target strategy may create opportunities for innovative therapeutics with new mechanisms of action that are not achievable with single specificity antibodies. The company will initially focus its Zybody development on therapies for various cancers and autoimmune disorders while emphasizing cost-effective discovery, manufacturing and clinical development practices.